Transforming Oncology: Redefining Cancer Care, Pursuing Cures for Every Form with Bold Ambitions.

At the forefront of a revolutionary oncology movement, we are committed to redefining cancer care and pursuing cures for all cancer forms. Our dedication to following the science enables us to comprehend cancer's complexities fully, leading to the discovery, development, and delivery of life-changing treatments that have the potential to save lives worldwide. Our Oncology strategy is centered around pushing the boundaries of science, transforming medical practices, and profoundly impacting the lives of cancer patients. With a diverse pipeline of next-generation medicines and an unwavering focus on execution excellence, we strive to expand treatment options and enhance outcomes for patients with solid tumors and hematological cancers. Our approach revolves around four strategic priorities: pioneering research across six scientific platforms, advancing innovative clinical strategies for various disease stages, building expertise and leadership in high mortality rate tumour types, and delivering impact across our global footprint.

News & Highlights

Read all articles

  • 28 Sep 2023

    Ovarian Cancer Forum "In the Era of Precision Medicine"

    Read more

  • 01 jun 2020

    AZ Spotlight | ESMO 2023 Hybrid Congress

    Read more

  • Breast Cancer

    แนวทางการตรวจคัดกรองวินิจฉัย และรักษา โรคมะเร็งเต้านม

    Read more

  • Genetic Testing

    แนวทางการตรวจยีน BRCA1/BRCA2

    Read more

4 march 2020

 Surrey UK

Shifting Perspectives of Antiplatelet Therapy: NSTE-ACS in the Setting of COVID 19 – by Datuk Dr Rosli Mohd Ali

Join the webcast and listen to cardiology expert Datuk Dr Rosli Mohd Ali sharing his topic “Shifting Perspectives of Antiplatelet Therapy: NSTE-ACS in the Setting of COVID 19”.

Play video